• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO, INC. MEDLINE HCG PREGNANCY TEST CASSETTE (URINE); VISUAL, PREGNANCY HCG, PRESCRIPTION USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO, INC. MEDLINE HCG PREGNANCY TEST CASSETTE (URINE); VISUAL, PREGNANCY HCG, PRESCRIPTION USE Back to Search Results
Model Number FHC-102
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/12/2023
Event Type  malfunction  
Manufacturer Narrative
Conclusion pending completion of investigation.H3 other text : although requested, product has not been received for investigation.
 
Event Description
The customer reported two faint positive results when testing a patient urine sample with the medline hcg pregnancy test cassette (urine).The patient was being tested prior to receiving an iud.The customer stated that the physician then used a test from a different box, however the result was not specified, and no additional information was provided.The customer expressed some uncertainty as the accuracy of the two faint positive results.The customer did not clarify whether the patient had received the iud, however the customer did state that no treatment was provided or withheld on the basis of the two faint positive results.No adverse events were reported.
 
Event Description
The customer reported two faint positive results when testing a patient urine sample with the medline hcg pregnancy test cassette (urine).The patient was being tested prior to receiving an iud.The customer stated that the physician then used a test from a different box, however the result was not specified, and no additional information was provided.The customer expressed some uncertainty as the accuracy of the two faint positive results.The customer did not clarify whether the patient had received the iud, however the customer did state that no treatment was provided or withheld on the basis of the two faint positive results.No adverse events were reported.
 
Manufacturer Narrative
D4 updated with expiration date.H4 updated with date of manufacture.H6 and h10 updated to reflect outcome of investigation.Investigation conclusion: retained devices from the reported lot number were tested with hcg-negative clinical urine samples.The results were read at 3 and 4 minutes and all devices yielded the expected negative results.No false positive results were observed during in-house testing.The case details were reviewed along with the complaint history for the reported issue and no indications of a systemic issue were identified.Manufacturing batch record review did not uncover any relevant non-conformances and found that the lot met quality control specifications.Review of the risk management report for this product found that the reported issue is within the risk profile for this device; no new hazard has been identified.A root cause could not be determined from the available information as the reported issue was not replicated during testing of retention product.Complaints are tracked and trended on a monthly basis.Per the package insert: ¿ very low levels of hcg (less than 50 miu/ml) are present in urine specimen shortly after implantation.However, because a significant number of first trimester pregnancies terminate for natural reasons, a test result that is weakly positive should be confirmed by retesting with a first morning urine specimen collected 48 hours later.¿ a number of conditions other than pregnancy, including trophoblastic disease and certain non-trophoblastic neoplasms including testicular tumors, prostate cancer, breast cancer, and lung cancer, cause elevated levels of hcg.Therefore, the presence of hcg in urine should not be used to diagnose pregnancy unless these conditions have been ruled out.¿ this test provides a presumptive diagnosis for pregnancy.A confirmed pregnancy diagnosis should only be made by a physician after all clinical and laboratory findings have been evaluated.H3 other text : although requested, product has not been received for investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEDLINE HCG PREGNANCY TEST CASSETTE (URINE)
Type of Device
VISUAL, PREGNANCY HCG, PRESCRIPTION USE
Manufacturer (Section D)
ALERE SAN DIEGO, INC.
9942 mesa rim rd
san diego CA 92121
Manufacturer Contact
monika burrell
9942 mesa rim rd
san diego, CA 92121
8588052506
MDR Report Key17857932
MDR Text Key324772911
Report Number2027969-2023-00089
Device Sequence Number1
Product Code JHI
UDI-Device Identifier30888277191871
UDI-Public(01)30888277191871(17)240430(10)HCG2052015
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K993317
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Distributor
Reporter Occupation Administrator/Supervisor
Type of Report Initial,Followup
Report Date 11/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/02/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2024
Device Model NumberFHC-102
Device Catalogue NumberMPH12025HCG
Device Lot NumberHCG2052015
Was Device Available for Evaluation? No
Date Manufacturer Received10/24/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/10/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age33 YR
Patient SexFemale
Patient RaceWhite
-
-